SE0302232D0 - Novel Compounds - Google Patents

Novel Compounds

Info

Publication number
SE0302232D0
SE0302232D0 SE0302232A SE0302232A SE0302232D0 SE 0302232 D0 SE0302232 D0 SE 0302232D0 SE 0302232 A SE0302232 A SE 0302232A SE 0302232 A SE0302232 A SE 0302232A SE 0302232 D0 SE0302232 D0 SE 0302232D0
Authority
SE
Sweden
Prior art keywords
novel compounds
useful
formula
relates
present
Prior art date
Application number
SE0302232A
Other languages
English (en)
Swedish (sv)
Inventor
Roger Bonnert
Rukhsana Rasul
Steve Thom
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0302232A priority Critical patent/SE0302232D0/xx
Publication of SE0302232D0 publication Critical patent/SE0302232D0/xx
Priority to TW093123728A priority patent/TW200510303A/zh
Priority to US10/568,889 priority patent/US7709521B2/en
Priority to AT04768065T priority patent/ATE484494T1/de
Priority to MYPI20043328A priority patent/MY143367A/en
Priority to JP2006523677A priority patent/JP4709758B2/ja
Priority to DE602004029580T priority patent/DE602004029580D1/de
Priority to ES04768065T priority patent/ES2352201T3/es
Priority to DK04768065.7T priority patent/DK1656347T3/da
Priority to PT04768065T priority patent/PT1656347E/pt
Priority to SI200431554T priority patent/SI1656347T1/sl
Priority to PCT/GB2004/003502 priority patent/WO2005019171A1/en
Priority to SA04250255A priority patent/SA04250255B1/ar
Priority to EP04768065A priority patent/EP1656347B1/en
Priority to PL04768065T priority patent/PL1656347T3/pl
Priority to UY28473A priority patent/UY28473A1/es
Priority to ARP040102959A priority patent/AR045462A1/es
Priority to CY20101101133T priority patent/CY1110977T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/36—Oxygen atoms in position 3, e.g. adrenochrome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE0302232A 2003-08-18 2003-08-18 Novel Compounds SE0302232D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE0302232A SE0302232D0 (sv) 2003-08-18 2003-08-18 Novel Compounds
TW093123728A TW200510303A (en) 2003-08-18 2004-08-06 Novel compounds
PL04768065T PL1656347T3 (pl) 2003-08-18 2004-08-16 Podstawione pochodne indolu do środków farmaceutycznych do leczenia chorób układu oddechowego
DK04768065.7T DK1656347T3 (da) 2003-08-18 2004-08-16 Substituerede indolderivater til farmaceutisk sammensætning til behandling af luftvejssygdomme
PT04768065T PT1656347E (pt) 2003-08-18 2004-08-16 Derivados de indole substituídos para composição farmacêutica para tratar doenças respiratórias
MYPI20043328A MY143367A (en) 2003-08-18 2004-08-16 Substituted indole derivatives for pharmaceutical compositions for treating respiratory diseases
JP2006523677A JP4709758B2 (ja) 2003-08-18 2004-08-16 呼吸器系疾患の処置用医薬組成物のための置換インドール誘導体
DE602004029580T DE602004029580D1 (de) 2003-08-18 2004-08-16 Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
ES04768065T ES2352201T3 (es) 2003-08-18 2004-08-16 Derivados de indol sustituidos para composiciones farmacéuticas para tratar enfermedades respiratorias.
US10/568,889 US7709521B2 (en) 2003-08-18 2004-08-16 Substituted indole derivatives for pharmaceutical compositions for treating respiratory diseases
AT04768065T ATE484494T1 (de) 2003-08-18 2004-08-16 Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
SI200431554T SI1656347T1 (sl) 2003-08-18 2004-08-16 Substituirani indolni derivati za farmacevtske sestavke za zdravljenje respiratornih bolezni
PCT/GB2004/003502 WO2005019171A1 (en) 2003-08-18 2004-08-16 Substituted indole derivatives for pharmaceutical composition for treating respiratory diseases
SA04250255A SA04250255B1 (ar) 2003-08-18 2004-08-16 مشتقات اندول مستبدلة لعمل تركيبات صيدلانية لعلاج امراض يسببها بروستجلاندين d2
EP04768065A EP1656347B1 (en) 2003-08-18 2004-08-16 Substituted indole derivatives for pharmaceutical composition for treating respiratory diseases
UY28473A UY28473A1 (es) 2003-08-18 2004-08-17 Nuevos compuestos
ARP040102959A AR045462A1 (es) 2003-08-18 2004-08-18 DERIVADOS DE INDOLES SUSTITUIDOS eTILES COMO COMPUESTOS FARMACEUTICOS PARA EL TRATAMIENTO DE ENFERMEDADES RESPIRATORIAS
CY20101101133T CY1110977T1 (el) 2003-08-18 2010-12-09 Υποκατεστημενα παραγωγα ινδολης για φαρμακευτικη συνθεση για θεραπεια ασθενειων του αναπνευστικου

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302232A SE0302232D0 (sv) 2003-08-18 2003-08-18 Novel Compounds

Publications (1)

Publication Number Publication Date
SE0302232D0 true SE0302232D0 (sv) 2003-08-18

Family

ID=28450248

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302232A SE0302232D0 (sv) 2003-08-18 2003-08-18 Novel Compounds

Country Status (18)

Country Link
US (1) US7709521B2 (cg-RX-API-DMAC10.html)
EP (1) EP1656347B1 (cg-RX-API-DMAC10.html)
JP (1) JP4709758B2 (cg-RX-API-DMAC10.html)
AR (1) AR045462A1 (cg-RX-API-DMAC10.html)
AT (1) ATE484494T1 (cg-RX-API-DMAC10.html)
CY (1) CY1110977T1 (cg-RX-API-DMAC10.html)
DE (1) DE602004029580D1 (cg-RX-API-DMAC10.html)
DK (1) DK1656347T3 (cg-RX-API-DMAC10.html)
ES (1) ES2352201T3 (cg-RX-API-DMAC10.html)
MY (1) MY143367A (cg-RX-API-DMAC10.html)
PL (1) PL1656347T3 (cg-RX-API-DMAC10.html)
PT (1) PT1656347E (cg-RX-API-DMAC10.html)
SA (1) SA04250255B1 (cg-RX-API-DMAC10.html)
SE (1) SE0302232D0 (cg-RX-API-DMAC10.html)
SI (1) SI1656347T1 (cg-RX-API-DMAC10.html)
TW (1) TW200510303A (cg-RX-API-DMAC10.html)
UY (1) UY28473A1 (cg-RX-API-DMAC10.html)
WO (1) WO2005019171A1 (cg-RX-API-DMAC10.html)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201635D0 (sv) 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) * 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301569D0 (sv) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
SE0303180D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
ES2304010T3 (es) 2004-03-11 2008-09-01 Actelion Pharmaceuticals Ltd. Derivados de tetrahidropiridoindol.
DK1833791T3 (da) 2004-12-27 2011-10-24 Actelion Pharmaceuticals Ltd 2,3,4,9-tetrahydor-1H-carbazolderivater som CRTH2 receptorantagonister
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
GB0505048D0 (en) * 2005-03-11 2005-04-20 Oxagen Ltd Compounds with PGD antagonist activity
WO2007010964A1 (ja) 2005-07-22 2007-01-25 Shionogi & Co., Ltd. Ｐｇｄ２受容体アンタゴニスト活性を有するインドール誘導体
JP5064219B2 (ja) 2005-07-22 2012-10-31 塩野義製薬株式会社 Ｐｇｄ２受容体アンタゴニスト活性を有するアザインドール酸誘導体
GB0521275D0 (en) * 2005-10-19 2005-11-30 Argenta Discovery Ltd 3-Aminoindole compounds
JP2009538289A (ja) * 2006-05-26 2009-11-05 アストラゼネカ・アクチエボラーグ ビアリールまたはヘテロアリール置換インドール
ES2618352T3 (es) 2006-06-16 2017-06-21 The Trustees Of The University Of Pennsylvania Antagonistas del receptor de prostaglandina D2 para el tratamiento de la alopecia androgenética
US20150072963A1 (en) * 2006-06-16 2015-03-12 The Trustees Of The University Of Pennsylvania Compositions and methods for regulating hair growth
EP2492268A1 (en) 2006-07-22 2012-08-29 Oxagen Limited Compounds having CRTH2 antagonist activity
KR101411820B1 (ko) 2006-08-07 2014-06-24 액테리온 파마슈티칼 리미티드 (3-아미노-1,2,3,4-테트라하이드로-9ｈ-카르바졸-9-일)-아세트산 유도체
PT2133332E (pt) 2007-04-11 2013-10-03 Kissei Pharmaceutical Derivado de (aza)indole e sua utilização para fins médicos
US7960567B2 (en) * 2007-05-02 2011-06-14 Amgen Inc. Compounds and methods useful for treating asthma and allergic inflammation
ATE502920T1 (de) 2007-12-14 2011-04-15 Pulmagen Therapeutics Asthma Ltd Indole und ihre therapeutische verwendung
PT2250161E (pt) 2008-01-18 2014-01-21 Atopix Therapeutics Ltd Compostos tendo atividade antagonista de crth2
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
EP2240444A1 (en) 2008-01-22 2010-10-20 Oxagen Limited Compounds having crth2 antagonist activity
WO2009093026A1 (en) 2008-01-22 2009-07-30 Oxagen Limited Compounds having crth2 antagonist activity
WO2009151910A2 (en) * 2008-05-25 2009-12-17 Wyeth Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
MY150774A (en) 2008-12-25 2014-02-28 Taisho Pharmaceutical Co Ltd Isoquinoline derivative
SG176571A1 (en) * 2009-05-19 2012-01-30 Vivia Biotech Sl Methods for providing personalized medicine tests ex vivo for hematological neoplasms
JP5675800B2 (ja) * 2009-07-06 2015-02-25 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ ４−（アセチルアミノ））−３−［（４−クロロ−フェニル）チオ］−２−メチル−１ｈ−インドール−１−酢酸の製造のための中間体および方法
AU2011215638B2 (en) * 2010-02-11 2016-04-28 Vanderbilt University Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as mGluR4 allosteric potentiators, compounds, and methods of treating neurological dysfunction
EP2558447B1 (en) 2010-03-22 2014-09-17 Actelion Pharmaceuticals Ltd. 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
PH12012502478A1 (en) 2010-06-23 2014-10-17 Taisho Pharmaceutical Co Ltd Isoquinoline derivative
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
CA2830204C (en) 2011-04-14 2019-04-09 Actelion Pharmaceuticals Ltd 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
EP2526945A1 (en) 2011-05-25 2012-11-28 Almirall, S.A. New CRTH2 Antagonists
EP2548863A1 (en) 2011-07-18 2013-01-23 Almirall, S.A. New CRTh2 antagonists.
EP2548876A1 (en) 2011-07-18 2013-01-23 Almirall, S.A. New CRTh2 antagonists
WO2013088109A1 (en) 2011-12-16 2013-06-20 Oxagen Limited Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
EA033143B1 (ru) 2012-03-21 2019-09-30 Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания Способ и применение селективного антагониста dp-2 по отношению к dp-1 для стимулирования роста волос
EA030159B1 (ru) 2014-03-17 2018-06-29 Идорсиа Фармасьютиклз Лтд Производные азаиндолуксусной кислоты и их применение в качестве модуляторов рецепторов простагландина d2
JP6484644B2 (ja) 2014-03-18 2019-03-13 イドーシア ファーマシューティカルズ リミテッドＩｄｏｒｓｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ アザインドール酢酸誘導体及びプロスタグランジンｄ２受容体調節剤としてのそれらの使用
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
TWI695831B (zh) 2014-09-13 2020-06-11 香港商南北兄弟藥業投資有限公司 Ｃｒｔｈ２拮抗劑化合物及其用途
US20180021302A1 (en) 2015-02-13 2018-01-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus
BR112018002012A2 (pt) 2015-07-30 2018-09-18 Univ Pennsylvania alelos polimórficos de nucleotídeo único de gene dp-2 humano para detecção de suscetibilidade à inibição do crescimento de cabelos por pgd2
UA123156C2 (uk) 2015-09-15 2021-02-24 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА ФОРМА (S)-2-(8-((5-ХЛОРПІРИМІДИН-2-ІЛ)(МЕТИЛ)АМІНО)-2-ФТОР-6,7,8,9-ТЕТРАГІДРО-5H-ПІРИДО[3,2-b]ІНДОЛ-5-ІЛ)ОЦТОВОЇ КИСЛОТИ, ЇЇ ЗАСТОСУВАННЯ ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЇЇ МІСТИТЬ
CA3200111C (en) * 2020-10-28 2025-02-18 Shionogi & Co., Ltd. AMIDE DERIVATIVE WITH ANTIVIRAL ACTIVITY

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790679A (fr) 1971-11-03 1973-04-27 Ici Ltd Derives de l'indole
JPH0615542B2 (ja) 1986-07-22 1994-03-02 吉富製薬株式会社 ピラゾロピリジン化合物
US5095031A (en) * 1990-08-20 1992-03-10 Abbott Laboratories Indole derivatives which inhibit leukotriene biosynthesis
WO1993005020A1 (en) 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase
FR2692574B1 (fr) 1992-06-23 1995-06-23 Sanofi Elf Derives hydroxy-4 benzenethio, leur preparation ainsi que leur utilisation pour la preparation de derives aminoalkoxybenzenesulfonyles.
JPH08507067A (ja) 1993-02-24 1996-07-30 メルク エンド カンパニー インコーポレーテッド Ｈｉｖ逆転写酵素阻害剤
US5486525A (en) 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
US5567711A (en) 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
TW472045B (en) 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
WO1999009007A1 (en) 1997-08-21 1999-02-25 American Home Products Corporation Solid phase synthesis of 2,3-disubstituted indole compounds
CA2315226A1 (en) 1997-12-19 1999-07-01 Eli Lilly And Company Hypoglycemic imidazoline compounds
US6916841B2 (en) 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
WO2000078761A1 (en) 1999-06-23 2000-12-28 Sepracor, Inc. Indolyl-benzimidazole antibacterials, and methods of use thereof
AU7962200A (en) 1999-10-29 2001-05-14 Wakunaga Pharmaceutical Co., Ltd Novel indole derivatives and drugs containing the same as the active ingredient
SK288019B6 (sk) 1999-12-24 2012-11-05 Aventis Pharma Limited Azaindoles derivatives, their use and pharmaceutical composition containing thereof
BR0111230A (pt) * 2000-05-31 2003-06-10 Astrazeneca Ab Composto, e, uso e processo para a preparação do mesmo
US6878522B2 (en) 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
TWI317634B (en) 2001-12-13 2009-12-01 Nat Health Research Institutes Aroyl indoles compounds
PL373410A1 (en) * 2002-02-01 2005-08-22 F.Hoffman-La Roche Ag Substituted indoles as alpha-1 agonists
SE0200356D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200411D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
US7534897B2 (en) 2002-05-16 2009-05-19 Shionogi & Co., Ltd. Indole arylsulfonaimide compounds exhibiting PGD 2 receptor antagonism
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0201635D0 (sv) * 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0202463D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab Novel compounds
SE0301569D0 (sv) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
WO2005040114A1 (en) 2003-10-14 2005-05-06 Oxagen Limited Compounds having crth2 antagonist activity
SE0303180D0 (sv) 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
GB2422831A (en) 2005-02-04 2006-08-09 Oxagen Ltd Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
JP2009538289A (ja) 2006-05-26 2009-11-05 アストラゼネカ・アクチエボラーグ ビアリールまたはヘテロアリール置換インドール
CA2654026A1 (en) 2006-06-08 2007-12-13 Neurokey A/S Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
CN101478962A (zh) 2006-06-28 2009-07-08 塞诺菲-安万特股份有限公司 新的cxcr2抑制剂

Also Published As

Publication number Publication date
DE602004029580D1 (de) 2010-11-25
PL1656347T3 (pl) 2011-02-28
DK1656347T3 (da) 2011-01-10
EP1656347A1 (en) 2006-05-17
UY28473A1 (es) 2005-03-31
US20060264444A1 (en) 2006-11-23
TW200510303A (en) 2005-03-16
JP2007502804A (ja) 2007-02-15
EP1656347B1 (en) 2010-10-13
AR045462A1 (es) 2005-10-26
ATE484494T1 (de) 2010-10-15
ES2352201T3 (es) 2011-02-16
SI1656347T1 (sl) 2011-01-31
US7709521B2 (en) 2010-05-04
MY143367A (en) 2011-04-29
WO2005019171A1 (en) 2005-03-03
SA04250255B1 (ar) 2009-02-25
CY1110977T1 (el) 2015-06-11
PT1656347E (pt) 2010-12-09
JP4709758B2 (ja) 2011-06-22

Similar Documents

Publication Publication Date Title
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
SE0201635D0 (sv) Novel compounds
SE0202241D0 (sv) Novel Compounds
TW200510301A (en) Novel compounds
SE0301373D0 (sv) Novel compounds
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
CY1109854T1 (el) Παραγωγα αζαδικυκλο(3.1.0)εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
WO2007138282A3 (en) Bi-aryl or aryl-heteroaryl substituted indoles
EA200601141A1 (ru) Сульфонамидные производные для лечения заболеваний
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
MX2007011695A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
MY153719A (en) Prokineticin 1 receptor antagonists
MX2007011847A (es) Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
TW200728258A (en) Novel compounds
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
GB0519760D0 (en) Novel compounds
DE602006014022D1 (de) 5-substituierte indol-2-carbonsäureamidderivate
EA200602080A1 (ru) Пиперазиновые производные алкилоксиндолов
CY1106649T1 (el) Νεα 1-μεθοξυ-2-φαινυλ-αιθενια χρησιμα δια την παρασκευην 5-καρβοξαλδεϋδο-2,3-διϋδροβενζοξεπινων
SE0301798D0 (sv) New use IV